Cited by 479NF-κB Signaling PathwaysImmune Response and InflammationSignaling Pathways in Disease

Severe liver degeneration and lack of NF-κ B activation in NEMO/IKKγ-deficient mice

Open access
Rudolph, Dorothea, Yeh, Wen-Chen, Wakeham, Andrew, Rudolph, Bettina, Nallainathan, Dhani, Potter, Julia, Elia, Andrew J., Mak, Tak W.·2000·Genes & Development

Abstract

Phosphorylation of IκB, an inhibitor of NF-κB, is an important step in the activation of the transcription factor NF-κB. Phosphorylation is mediated by the IκB kinase (IKK) complex, known to contain two catalytic subunits: IKKα and IKKβ. A novel, noncatalytic component of this kinase complex called NEMO(NF-κBe ssential mo dulator)/IKKγ was identified recently. We have generated NEMO/IKKγ-deficient mice by gene targeting. Mutant embryos die at E12.5–E13.0 from severe liver damage due to apoptosis.NEMO/IKKγ-deficient primary murine embryonic fibroblasts (MEFs) lack detectable NF-κB DNA-binding activity in response to TNFα, IL-1, LPS, and Poly(IC) and do not show stimulus-dependent IκB kinase activity, which correlates with a lack of phosphorylation and degradation of IκBα. Consistent with these data, mutant MEFs show increased sensitivity to TNFα-induced apoptosis. Our data provide in vivo evidence that NEMO/IKKγ is the first essential, noncatalytic component of the IKK complex.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1101/gad.14.7.854

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Cellular senescence is involved in the progression of liver disease.

    “Cellular senescence is implicated in the progression of liver disease.”

    From Senolytic Drugs: Reducing Senescent Cell Viability to Extend Health Span (2021) · cites this paper as [63]

    The “Liver degeneration in NEMO/IKKγ-deficient embryos” section attributes liver damage in mutant embryos to apoptosis, but does not address cellular senescence or the progression of liver disease. Searches for “cellular senescence liver disease progression” and “senescence senescent cells” found no passage addressing that link. (LLM, conf=0.76)

    Experimental — accuracy not yet measured
  • Telomere dysfunction, a major driver of hepatocyte senescence, impairs liver regeneration and causes liver cirrhosis in mice.

    “Telomere dysfunction, a major driver of hepatocyte senescence, impairs liver regeneration and induces liver cirrhosis in mice (63).”

    From Senolytic Drugs: Reducing Senescent Cell Viability to Extend Health Span (2021) · cites this paper as [63]

    The Abstract and “Liver degeneration in NEMO/IKKγ-deficient embryos” section describe embryonic liver apoptosis following NEMO/IKKγ deficiency. Searches for telomere dysfunction, hepatocyte senescence, liver regeneration, and cirrhosis found no passage in our copy addressing the attributed claim. (LLM, conf=0.76)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 27 · Cited by 479

Authors
Rudolph, D., Yeh, W.-C., Wakeham, A., Rudolph, B., Nallainathan, D., Potter, J., Elia, A. J., & Mak, T. W.
Affiliations
University of Toronto (CA)
Venue
Genes & Development
Published
2000-04-01
Volume
14
Issue
7
Pages
854-862
ISSN
  • 0890-9369 (ISSN-L)
  • 1549-5477
OpenAlex
W4297063097
Cited by
479
References
27
Citations by year
2026: 3 · 2025: 2 · 2024: 6 · 2023: 3 · 2022: 8 · 2021: 11 · 2020: 9 · 2019: 12 · 2018: 5 · 2017: 9 · 2016: 14 · 2015: 10 · 2014: 19 · 2013: 17 · 2012: 15
Type
posted content
Language
en
Open access
Locations
Genes & Development (publishedVersion)
Funders
Deutsche Forschungsgemeinschaft
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
  • Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Signaling Pathways in Disease
Keywords
NEMO/IKKγ, NF-κB activation, IκB kinase complex, IκBα phosphorylation, liver degeneration, embryonic lethality, apoptosis, TNFα-induced apoptosis, embryonic fibroblasts, gene targeting

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review